ENFUSION, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • October 12th, 2021 • Enfusion, Inc. • Services-prepackaged software • Delaware
This Indemnification Agreement (“Agreement”) is made as of ________________ by and between Enfusion, Inc., a Delaware corporation (the “Company”), and ____________ (“Indemnitee”).
SENIOR SECURED CREDIT FACILITIES AMENDED AND RESTATED CREDIT AGREEMENT dated as of October [__], 2021, among ENFUSION, INC., as Holdings, ENFUSION LTD. LLC, as Borrower, THE SEVERAL LENDERS FROM TIME TO TIME PARTY HERETO, and SILICON VALLEY BANK, as...Credit Agreement • October 12th, 2021 • Enfusion, Inc. • Services-prepackaged software • New York
THIS AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”), dated as of October [__], 2021, is entered into by and among ENFUSION, INC., a Delaware corporation (“Holdings”), ENFUSION LTD. LLC, a Delaware limited liability company (the “Borrower”), the several banks and other financial institutions or entities from time to time party to this Agreement as lenders, including pursuant to Sections 2.27 or 10.6 (each a “Lender” and, collectively, the “Lenders”), SILICON VALLEY BANK (“SVB”), as the Issuing Lender, and SVB, as administrative agent and collateral agent for the Lenders (in such capacities, the “Administrative Agent”).
ENFUSION, INC. REGISTRATION RIGHTS AGREEMENT [DATE], 2021Registration Rights Agreement • October 12th, 2021 • Enfusion, Inc. • Services-prepackaged software • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of the [•] day of [•], 2021, by and among Enfusion, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
Shares ENFUSION, INC. CLASS A COMMON STOCK (PAR VALUE $0.001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2021 • Enfusion, Inc. • Services-prepackaged software • New York
Enfusion, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Morgan Stanley & Co. LLC (“Morgan Stanley”) and Goldman Sachs & Co. LLC (“Goldman Sachs”) are acting as representatives (the “Representatives”) and certain shareholders of the Company (the “Selling Shareholders”) named in Schedule III hereto severally propose to sell to the several Underwriters, an aggregate of [·] shares of the Class A common stock of the Company (par value $0.001 per share) (the “Firm Shares”), of which [·] shares are to be issued and sold by the Company and [·] shares are to be sold by the Selling Shareholders, each Selling Shareholder selling the amount set forth opposite such Selling Shareholder’s name in Schedule III hereto.
TAX RECEIVABLE AGREEMENT between ENFUSION, INC. and THE PERSONS NAMED HEREIN Dated as of [], 2021Tax Receivable Agreement • October 12th, 2021 • Enfusion, Inc. • Services-prepackaged software • New York
This TAX RECEIVABLE AGREEMENT (this “Agreement”) is dated as of [], 2021, and is between Enfusion, Inc., a Delaware corporation, each of the undersigned parties, and each of the other persons from time to time that becomes a party hereto (each, excluding Enfusion Ltd. LLC, a Delaware limited liability company (“OpCo”), a “TRA Party”).
ENFUSION LTD. LLC SEVENTH AMENDED AND RESTATED OPERATING AGREEMENT Dated as of [_____], 2021Operating Agreement • October 12th, 2021 • Enfusion, Inc. • Services-prepackaged software • Delaware
This Seventh Amended and Restated Operating Agreement, dated as of [•], 2021 (this “Agreement”), is entered into by and among Enfusion Ltd. LLC, a Delaware limited liability company (the “Company”), Enfusion, Inc., a Delaware corporation, on its behalf, FTV Enfusion Holdings, Inc., a Delaware corporation, as Managing Member and Member (“FTV Blocker”), Enfusion US 1, Inc., a Delaware corporation, as successor Managing Member to FTV Blocker and Member (“NewCo 1”) and the other Members. Capitalized terms used herein without definition shall have the meanings assigned to such terms in Article I.
